Starpharma Holdings Limited

Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and VivaGel. Starpharma has developed VIRALEZE, an antiviral nasal spray for COVID-19, which is complementary to vaccines and other preventative measures such as distancing and PPE. VIRALEZE is registered for sale in the UK/Europe and available in the UK through LloydsPharmacy. SPL7013 is utilised in approved products - the VivaGel condom and VivaGel BV. VivaGel BV has been licensed in >160 countries, is approved in >40 countries and available for sale in the UK, Europe, Japan, South East Asia, Australia and New Zealand.